Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.

[1]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[2]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  A. Ganser,et al.  Who Is the Best Hematopoietic Stem-Cell Donor for a Male Patient With Acute Leukemia? , 2014, Transplantation.

[4]  R. Storb,et al.  Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation , 2014, Bone Marrow Transplantation.

[5]  W. Wiktor-Jedrzejczak,et al.  Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice , 2014, Bone Marrow Transplantation.

[6]  F. Locatelli,et al.  Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation , 2014, Expert opinion on pharmacotherapy.

[7]  S. Paczesny.  Discovery and validation of graft-versus-host disease biomarkers. , 2011, Blood.

[8]  D. Blaise,et al.  Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation? , 2012, Hematology. American Society of Hematology. Education Program.

[9]  J. Wingard,et al.  First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  M. MacMillan,et al.  What predicts high risk acute graft‐versus‐host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score , 2012, British journal of haematology.

[11]  B. Djulbegovic,et al.  Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review , 2012, Leukemia.

[12]  R. Porcher,et al.  Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  E. Shpall,et al.  Steroid-Refractory Acute GVHD: Predictors and Outcomes , 2011, Advances in hematology.

[14]  D. Porter,et al.  Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. , 2011, Blood.

[15]  R. Storb,et al.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. , 2011, Blood.

[16]  Franz Király,et al.  Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. MacMillan,et al.  The best endpoint for acute GVHD treatment trials. , 2010, Blood.

[18]  F. M. Stewart,et al.  Comparison of Matched Unrelated and Matched Related Donor Myeloablative Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia in First Remission , 2010, Leukemia.

[19]  B. Sandmaier,et al.  Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  R. Porcher,et al.  Initial Liver Involvement in Acute GVHD is Predictive for Nonrelapse Mortality , 2009, Transplantation.

[21]  A. Gratwohl,et al.  Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  R. Gale,et al.  Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Christoph Schmid,et al.  Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Brand,et al.  Female‐Versus‐Male Alloreactivity as a Model for Minor Histocompatibility Antigens in Hematopoietic Stem Cell Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Jonas Mattsson,et al.  Graft failure after allogeneic hematopoietic cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  M. Sorror,et al.  Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  K. Sullivan.  Graft‐vs.‐Host Disease , 2007 .

[28]  G. Gahrton.  Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation. , 2007, Best practice & research. Clinical haematology.

[29]  R. Herrmann,et al.  Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[30]  J. Bourhis,et al.  Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  N. Kröger,et al.  Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation , 2006, Bone Marrow Transplantation.

[32]  V. Diehl,et al.  Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  R. Verdijk,et al.  Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. , 2004, Blood.

[34]  T. Mutis,et al.  Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation , 2003, The Lancet.

[35]  M. Lindemann,et al.  Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. , 2003, Blood.

[36]  E. Simpson,et al.  Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. , 2003, Blood.

[37]  C. Kollman,et al.  Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. , 2002, Blood.

[38]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.